Product Development

In Vitro and In Vivo Testing

Experienced, in-house testing

Alira Health offers a broad range of in vitro and in vivo testing services, led by the expertise of our experienced in-house scientists.

Access and design the right test

With multiple methodologies available for evaluation of your product, our scientists will help you select or design a test that meets your needs:
  • Biofilm studies and antimicrobial formulations
  • Genetic and enzymatic profiling (qPCR, ELISA, FRET, immunostaining)
  • Biomechanical testing and wound healing models, 3D tumor models and 3D bioprinting

In vitro and in vivo testing options

Our expertise covers the performance of individualized pharmaceutical drug tests to analyze efficacy on target cells of systemic therapy for both in vitro and in vivo.

In vitro testing

In vitro testing is an important alternative to animal testing, and Alira Health offers a range of in vitro testing options. Our in vitro testing laboratories offer cell-based biological and non-biological methods for safety and toxicity testing from a range of industries. In vitro testing services include:

  • Cell models for inflammation, migration, 3D tumor, and apoptosis
  • Gene Expression (qPCR) and Immunocytochemistry
  • Microbiology and Biofilm Models
  • Fluorescent and colorimetric microplate assays

In vivo testing

Alira Health scientists are experienced in conducting in vivo testing for the purposes of efficacy and safety. In vivo testing services include:

  • Animal models in wound repair and regeneration
  • Infection and biofilm models
  • Mouse tumor survival models

Why choose Alira Health?

As our partner, you’ll work closely with our team of experienced scientists to leverage their:

  • More than three decades experience in preclinical models for wound repair and regeneration
  • Leading expertise in biofilm and preclinical infection models
  • Rapid turnaround and responsiveness to client requirements and deadlines

Related news

MedTech
News March 3, 2021
The 2021 MedTech Contract Manufacturing Report
Download our latest piece: The 2021 MedTech Contract Manufacturing Report. Learn how despite the ongoing pandemic, the Medical Device and CDMO industries are positioned to perform(...)
M&A
Publications February 28, 2021
What’s most important when selecting a firm for your next transaction?
Market Access MedTech
Multimedia February 26, 2021
Pricing in MedTech: Disentangling the Roles of Payers, DRGs, and Procurement
Join host Kenny Carberry, Associate Director of Clinical Development, Dan Legg, former Director of Clinical Sourcing at Guy’s & St Thomas at the St Thomas Hospital in London and CEO(...)
M&A
Publications February 24, 2021
What You Should Know Before Choosing a Healthcare Transaction Advisory Firm
What’s most important when selecting a firm for your next transaction? Global experience, staff profiles, technical expertise? To learn more download our latest TAD Infographic.
MedTech Pharma
Publications February 8, 2021
Infographic: 2021 Trends in Healthcare
It is no secret that the COVID-19 pandemic has presented new challenges for businesses, and virtual has become the ‘new normal’, including for transactions.
MedTech Pharma
News February 4, 2021
2020 Year in Review
With 2021 in full swing, we want to take a moment to reflect on last year’s achievements and congratulate the entire Alira Health Team for their hard work and dedication to healthcare(...)
Regulatory
News February 2, 2021
We Secured Breakthrough Device Designation from FDA on PEDRA Xauron Perfusion System
We are proud to announce the firm’s Regulatory practice has secured a Breakthrough Device Designation from FDA for the real-time tissue perfusion system, PEDRA Xauron Perfusion System.

Our locations around the globe

Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.